• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚糖 276 依赖性识别的 HIV-1 广泛中和抗体的结构基础。

Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies.

机构信息

IAVI Neutralizing Antibody Center, Consortium for HIV/AIDS Vaccine Development (CHAVD), Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Duke University Human Vaccine Institute, Departments of Medicine and Surgery, Duke University School of Medicine, Durham, NC 27710, USA; Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery at Duke University, Durham, NC 27710, USA.

出版信息

Cell Rep. 2021 Nov 2;37(5):109922. doi: 10.1016/j.celrep.2021.109922.

DOI:10.1016/j.celrep.2021.109922
PMID:34731616
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9058982/
Abstract

Recognition of N-linked glycan at residue N276 (glycan276) at the periphery of the CD4-binding site (CD4bs) on the HIV-envelope trimer is a formidable challenge for many CD4bs-directed antibodies. To understand how this glycan can be recognized, here we isolate two lineages of glycan276-dependent CD4bs antibodies. Antibody CH540-VRC40.01 (named for donor-lineage.clone) neutralizes 81% of a panel of 208 diverse strains, while antibody CH314-VRC33.01 neutralizes 45%. Cryo-electron microscopy (cryo-EM) structures of these two antibodies and 179NC75, a previously identified glycan276-dependent CD4bs antibody, in complex with HIV-envelope trimer reveal substantially different modes of glycan276 recognition. Despite these differences, binding of glycan276-dependent antibodies maintains a glycan276 conformation similar to that observed in the absence of glycan276-binding antibodies. By contrast, glycan276-independent CD4bs antibodies, such as VRC01, displace glycan276 upon binding. These results provide a foundation for understanding antibody recognition of glycan276 and suggest its presence may be crucial for priming immunogens seeking to initiate broad CD4bs recognition.

摘要

识别 HIV 包膜三聚体 CD4 结合位点(CD4bs)周围残基 N276 上的 N 连接聚糖(聚糖 276),是许多针对 CD4bs 的抗体面临的巨大挑战。为了了解这种聚糖如何被识别,我们在这里分离出两种依赖聚糖 276 的 CD4bs 抗体谱系。抗体 CH540-VRC40.01(以供体谱系克隆命名)中和了 208 种不同株系的面板中的 81%,而抗体 CH314-VRC33.01 中和了 45%。这两种抗体与之前鉴定的依赖聚糖 276 的 CD4bs 抗体 179NC75 与 HIV 包膜三聚体复合物的冷冻电镜(cryo-EM)结构揭示了聚糖 276 识别的截然不同模式。尽管存在这些差异,但依赖聚糖 276 的抗体的结合保持了与未结合聚糖 276 结合抗体时观察到的相似的聚糖 276 构象。相比之下,如 VRC01 等不依赖聚糖 276 的 CD4bs 抗体在结合时会取代聚糖 276。这些结果为理解抗体对聚糖 276 的识别提供了基础,并表明其存在可能对启动寻求广泛 CD4bs 识别的免疫原至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/9058982/477cd4d0e46d/nihms-1798347-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/9058982/40a5b4582d87/nihms-1798347-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/9058982/f2c7fabe8929/nihms-1798347-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/9058982/c818cb9dbbf1/nihms-1798347-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/9058982/701c45b5ec8e/nihms-1798347-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/9058982/6423c6f47a4d/nihms-1798347-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/9058982/6c48753ebba3/nihms-1798347-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/9058982/477cd4d0e46d/nihms-1798347-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/9058982/40a5b4582d87/nihms-1798347-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/9058982/f2c7fabe8929/nihms-1798347-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/9058982/c818cb9dbbf1/nihms-1798347-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/9058982/701c45b5ec8e/nihms-1798347-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/9058982/6423c6f47a4d/nihms-1798347-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/9058982/6c48753ebba3/nihms-1798347-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/9058982/477cd4d0e46d/nihms-1798347-f0008.jpg

相似文献

1
Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies.聚糖 276 依赖性识别的 HIV-1 广泛中和抗体的结构基础。
Cell Rep. 2021 Nov 2;37(5):109922. doi: 10.1016/j.celrep.2021.109922.
2
Structure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding Site.靶向CD4结合位点附近一个罕见V5聚糖空洞的N276依赖性HIV-1中和抗体的结构
J Virol. 2016 Oct 28;90(22):10220-10235. doi: 10.1128/JVI.01357-16. Print 2016 Nov 15.
3
Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability.糖基化修饰的 HIV NFL 包膜三聚体脂质体疫苗诱导针对多个弱点的广谱中和抗体。
Immunity. 2019 Nov 19;51(5):915-929.e7. doi: 10.1016/j.immuni.2019.10.008. Epub 2019 Nov 12.
4
Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.基于中和作用的设计,产生了对 CH235 谱系 CD4bs 广谱中和抗体的未突变共同祖先具有高亲和力的 HIV-1 包膜三聚体。
PLoS Pathog. 2019 Sep 17;15(9):e1008026. doi: 10.1371/journal.ppat.1008026. eCollection 2019 Sep.
5
Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.去除保守的CD4结合位点近端聚糖导致的HIV-1包膜三聚体结构和抗原性变化
J Virol. 2016 Sep 29;90(20):9224-36. doi: 10.1128/JVI.01116-16. Print 2016 Oct 15.
6
Targeted N-glycan deletion at the receptor-binding site retains HIV Env NFL trimer integrity and accelerates the elicited antibody response.在受体结合位点进行靶向N-聚糖缺失可保留HIV Env NFL三聚体的完整性并加速引发的抗体反应。
PLoS Pathog. 2017 Sep 13;13(9):e1006614. doi: 10.1371/journal.ppat.1006614. eCollection 2017 Sep.
7
Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies.聚糖掩蔽作用聚焦于 HIV-1 的 CD4 结合位点的免疫反应,并增强了 VRC01 类前体抗体的产生。
Immunity. 2018 Aug 21;49(2):301-311.e5. doi: 10.1016/j.immuni.2018.07.005. Epub 2018 Jul 31.
8
HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.HIV-1 包膜糖基化修饰可被 VRC01 类种系返回复性的广泛中和抗体中和。
PLoS Pathog. 2018 Nov 5;14(11):e1007431. doi: 10.1371/journal.ppat.1007431. eCollection 2018 Nov.
9
An HIV-1 Env-Antibody Complex Focuses Antibody Responses to Conserved Neutralizing Epitopes.一种HIV-1包膜蛋白-抗体复合物使抗体反应聚焦于保守的中和表位。
J Immunol. 2016 Nov 15;197(10):3982-3998. doi: 10.4049/jimmunol.1601134. Epub 2016 Oct 10.
10
Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesign.疫苗诱导的灵长类动物抗体采用了一种独特的方法来结合 HIV-1 主要受体结合位点,为疫苗重新设计提供了信息。
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):E738-47. doi: 10.1073/pnas.1319512111. Epub 2014 Feb 3.

引用本文的文献

1
Transient glycan shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaques.短暂的聚糖屏蔽减少在感染SHIV的猕猴中诱导出结合CD4位点的广谱中和抗体。
Cell Rep. 2025 Jun 24;44(6):115848. doi: 10.1016/j.celrep.2025.115848. Epub 2025 Jun 13.
2
Acquisition of quaternary trimer interaction as a key step in the lineage maturation of a broad and potent HIV-1 neutralizing antibody.获得四级三聚体相互作用作为一种广泛且有效的HIV-1中和抗体谱系成熟的关键步骤。
Structure. 2025 Aug 7;33(8):1325-1336.e5. doi: 10.1016/j.str.2025.04.020. Epub 2025 May 23.
3
Cryo-electron microscopy in the study of virus entry and infection.

本文引用的文献

1
A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluation.一种用于生产 A 型和 C 型 HIV-1 包膜三聚体的非亲和性纯化工艺,用于临床评估。
Vaccine. 2021 Jun 8;39(25):3379-3387. doi: 10.1016/j.vaccine.2021.04.063. Epub 2021 May 18.
2
Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadth.接种疫苗可诱导多种未经突变的 VRC01 类 HIV 中和抗体前体在小鼠模型中成熟,具有 >50% 的广谱性。
Immunity. 2021 Feb 9;54(2):324-339.e8. doi: 10.1016/j.immuni.2020.12.014. Epub 2021 Jan 15.
3
低温电子显微镜在病毒进入与感染研究中的应用
Front Mol Biosci. 2024 Jul 24;11:1429180. doi: 10.3389/fmolb.2024.1429180. eCollection 2024.
4
B cell repertoire sequencing of HIV-1 pediatric elite-neutralizers identifies multiple broadly neutralizing antibody clonotypes.对HIV-1儿童精英中和者的B细胞受体库进行测序,鉴定出多种广泛中和抗体克隆型。
Front Immunol. 2024 Feb 16;15:1272493. doi: 10.3389/fimmu.2024.1272493. eCollection 2024.
5
HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide.由预融合稳定的包膜三聚体在人体内诱导产生的 HIV-1 中和抗体形成了一个可重复的针对融合肽的类别。
Cell Rep. 2023 Jul 25;42(7):112755. doi: 10.1016/j.celrep.2023.112755. Epub 2023 Jul 11.
6
Vaccination induces HIV broadly neutralizing antibody precursors in humans.接种疫苗可在人体内诱导产生 HIV 广谱中和抗体前体。
Science. 2022 Dec 2;378(6623):eadd6502. doi: 10.1126/science.add6502.
7
Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding site.结构基础研究揭示了 llama 纳米抗体识别和中和 HIV-1 于 CD4 结合位点的机制。
Structure. 2022 Jun 2;30(6):862-875.e4. doi: 10.1016/j.str.2022.03.012. Epub 2022 Apr 11.
Automated Design by Structure-Based Stabilization and Consensus Repair to Achieve Prefusion-Closed Envelope Trimers in a Wide Variety of HIV Strains.
基于结构的稳定化和共识修复的自动化设计,以实现在多种 HIV 株中达到预融合封闭的三聚体。
Cell Rep. 2020 Nov 24;33(8):108432. doi: 10.1016/j.celrep.2020.108432.
4
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes.基于结构的设计结合基于标签的纯化和过程中生物素化可简化 SARS-CoV-2 刺突分子探针的开发。
Cell Rep. 2020 Oct 27;33(4):108322. doi: 10.1016/j.celrep.2020.108322. Epub 2020 Oct 12.
5
UCSF ChimeraX: Structure visualization for researchers, educators, and developers.UCSF ChimeraX:面向研究人员、教育工作者和开发者的结构可视化工具。
Protein Sci. 2021 Jan;30(1):70-82. doi: 10.1002/pro.3943. Epub 2020 Oct 22.
6
Improvement of cryo-EM maps by density modification.通过密度修正提高冷冻电镜图谱质量。
Nat Methods. 2020 Sep;17(9):923-927. doi: 10.1038/s41592-020-0914-9. Epub 2020 Aug 17.
7
Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations.通过免疫复合物或蛋白质纳米颗粒制剂将HIV Env免疫原靶向非人类灵长类动物的B细胞滤泡。
NPJ Vaccines. 2020 Aug 5;5(1):72. doi: 10.1038/s41541-020-00223-1. eCollection 2020.
8
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody.高度广谱且强效的中和抗体限制 HIV-1 逃逸。
Cell. 2020 Feb 6;180(3):471-489.e22. doi: 10.1016/j.cell.2020.01.010. Epub 2020 Jan 30.
9
Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization.通过免疫克服 VRC01 HIV-1 中和抗体的空间位阻。
Cell Rep. 2019 Dec 3;29(10):3060-3072.e7. doi: 10.1016/j.celrep.2019.10.071.
10
Current developments in Coot for macromolecular model building of Electron Cryo-microscopy and Crystallographic Data.Coot 在电子冷冻显微镜和晶体学数据的大分子模型构建方面的最新进展。
Protein Sci. 2020 Apr;29(4):1069-1078. doi: 10.1002/pro.3791. Epub 2020 Mar 2.